Johnson & Johnson Innovation – JJDC, Inc.
Status
ACTIVE
Global HQ
Baltimore, United States
Countries of investment
- Hong Kong
Investment stages
- Advisory
Industries
- Fintech
- AI
- Blockchain
- Crypto
- Data Services
About
Johnson & Johnson Innovation – JJDC, Inc. (JJDC) is the strategic venture Capital arm of the Johnson & Johnson Family of Companies. JJDC is guided by a clear, consistent investment strategy aligned with the scientific goals of Johnson & Johnson, working handinhand with partners to help navigate the path to creating breakthrough health innovations. The firm invests across sectors—pharmaceuticals and medtech—at all stages, from new company creation and seedlevel startups to Series A and beyond, including private investments in public Equity (PIPEs). JJDC takes a longterm approach, deploying the full capabilities of the Johnson & Johnson Family of Companies, including discovery, clinical development, regulatory Affairs, manufacturing, and commercialization. The firm’s team comprises leaders in the healthcare and Technology communities, many of whom have deep R&D experience.
Johnson & Johnson Innovation – JJDC, Inc. (JJDC) is the strategic venture Capital arm of the Johnson & Johnson Family of Companies. JJDC is guided by a clear, consistent investment strategy aligned with the scientific goals of Johnson & Johnson, working handinhand with partners to help navigate the path to creating breakthrough health innovations. The firm invests across sectors—pharmaceuticals and medtech—at all stages, from new company creation and seedlevel startups to Series A and beyond, including private investments in public Equity (PIPEs). JJDC takes a longterm approach, deploying the full capabilities of the Johnson & Johnson Family of Companies, including discovery, clinical development, regulatory Affairs, manufacturing, and commercialization. The firm’s team comprises leaders in the healthcare and Technology communities, many of whom have deep R&D experience.
Investment Thesis
JJDC finds transformative ideas and helps them mature into potential solutions for today’s patients. JJDC invests across sectors—pharmaceuticals and medtech—and at all stages, from new company creation and seedlevel startups to Series A and beyond, including private investments in public Equity (PIPEs).
Portfolio
CARsgen Therapeutics